Skip to content

RNTX RNTX Change in Other Assets

Change in Other Assets at other companies

Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$91K+95.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$912K-83.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$7.84M-30.8%
LQD
Liquidia CorporationLQDA
$4.6M-0.5%
Insmed logo
InsmedINSM
$2.36M+123%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$670K-75.9%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's change in other assets?
RNTX (RNTX) reported change in other assets of -$103K in Q1 2026.
How has RNTX's change in other assets changed year-over-year?
RNTX's change in other assets decreased by 182.4% year-over-year, from $125K to -$103K.
What is the long-term trend for RNTX's change in other assets?
Over 2 years (2021 to 2024), RNTX's change in other assets has grown at a -32.1% compound annual growth rate (CAGR), from $291K to -$134K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.